Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q1 2023 · 10-Q
Revenue$2.52B$2.52B+4.8% vs Q1 2022 Net Income-$24.42M-$24.42MN/M vs Q1 2022 EPS Diluted-$0.32-$0.32N/M vs Q1 2022 Gross Profit$497,307,000+33.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Operating Cash Flow$158,398,000+98.7% Free Cash Flowderived$112,248,000+60.1% Margins · derivedGross margin19.7%+4.2 pt vs Q1 2022
Operating margin0.4%−2.1 pt vs Q1 2022
Net margin-1.0%−2.6 pt vs Q1 2022
ended Mar 31, 2023 · filed May 5, 2023 · 35 d after period end